Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy
Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy
复制标题
DOI：
10.1111/j.1469-0691.2004.00982.x
复制
发表时间：
2004-11-01
影响因子：
14.2
通讯作者：
Threlfall, EJ
中科院分区：
文献类型：
--
作者：
Cheasty, T;Day, M;Threlfall, EJ
Among shigellas isolated from patients in England and Wales in 2002, 10% of subgroups A, B and C, and 13% of subgroup D (Shigella sonnei), were resistant to nalidixic acid. As a consequence, should antimicrobial therapy be indicated, the efficacy of nalidixic acid as the preferred treatment for children with bacillary dysentery has been jeopardised.
